Filing Details

Accession Number:
0000950170-25-078982
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-29 16:17:48
Reporting Period:
2025-05-28
Filing Date:
2025-05-29
Accepted Time:
2025-05-29 16:17:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1880438 An2 Therapeutics Inc. ANTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873879 M Margaret Fitzpatrick C/O An2 Therapeutics, Inc.
1800 El Camino Real, Suite D
Menlo Park CA 94027
No No No No
Transaction Summary
Purchased: 8,610 shares Avg. Price: $1.18 Total Value: $10,133.11
Number of Shares After Transactions: 8,610 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-28 8,610 $1.18 8,610 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.